Mediwound Stock

Mediwound Dividend 2025

Mediwound Dividend

0 USD

Mediwound Dividend yield

Ticker

MDWD

ISIN

IL0011316309

WKN

A110TG

How much dividend does Mediwound 2025 pay?

According to the latest status from January 2025, Mediwound paid a total of 0 USD per share in dividends within the last 12 months. With the current Mediwound price of 17.99 USD, this corresponds to a dividend yield of 0 %. A dividend is paid times per year.

=

Historical Mediwound Dividends

A dividend is paid times per year. Last year, the payout months were and .

PaydateDividend

Is the Mediwound Dividend Safe?

Mediwound has been increasing the dividend for 0 years.

Over the past 10 years, Mediwound has increased it by an annual 0 %.

Over a five-year period, the distribution increased by 0%.

Analysts expect a Dividend Cut of -100% for the current fiscal year.

Dividend Details

Understanding Mediwound's Dividend Distributions

Mediwound’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining Mediwound's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

Mediwound's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in Mediwound’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

Mediwound Aktienanalyse

What does Mediwound do?

Mediwound Ltd is an Israeli company specializing in the development and marketing of therapies for chronic and acute wounds. The company was founded in 2000 and is headquartered in Yavne, Israel. Its history began with the idea of developing an innovative treatment method for burns. The company collaborated closely with the Israeli Ministry of Defense to find a better method for wound treatment. The result was the product NexoBrid, an enzymatic debridement treatment that aims to remove dead tissue from burn wounds to enable faster healing. Mediwound's business model is to develop and market innovative drugs and therapy solutions for wounds. The company operates in several areas, including burn wounds, chronic wounds, and trauma wounds. In the burn wounds sector, Mediwound offers the product NexoBrid, which enzymatically removes dead tissue from burns and eliminates neurotoxic substances that can damage wound healing if left in the tissue for too long. NexoBrid is already approved in several countries, including the USA and European countries. In the chronic wounds sector, Mediwound offers the product EscharEx, which is used to treat chronic wounds such as pressure ulcers, diabetic foot ulcers, and venous leg ulcers. EscharEx also uses an enzymatic approach and aims to remove dead tissue to enable the body's natural healing process. There are plans to launch EscharEx in Europe in the second half of 2021. Mediwound also operates in the trauma wounds sector and received the product MWPC003 in Europe in 2020. It is a novel enzymatic debriding product that can be used in the integrated therapy of complex trauma wounds with additional topical treatment options. Through the development of innovative therapies and drugs, Mediwound has established itself as a reliable partner in wound treatment. The company continues to focus on innovation and plans to expand its product range in the future. Overall, Mediwound Ltd is a groundbreaking company in the field of wound care. The company's products and solutions contribute to faster and more effective wound healing, improving the lives of patients worldwide. Mediwound is one of the most popular companies on Eulerpool.com.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Frequently Asked Questions about Mediwound stock

How much dividend does Mediwound pay?

Over the past 12 months, Mediwound paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Mediwound is expected to pay a dividend of 0 USD.

What is the dividend yield of Mediwound?

The current dividend yield of Mediwound is .

When does Mediwound pay dividends?

Mediwound pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Mediwound?

Mediwound paid dividends every year for the past 0 years.

What is the dividend of Mediwound?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Mediwound located?

Mediwound is assigned to the 'Health' sector.

Wann musste ich die Aktien von Mediwound kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Mediwound from 1/6/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 1/6/2025.

When did Mediwound pay the last dividend?

The last dividend was paid out on 1/6/2025.

What was the dividend of Mediwound in the year 2024?

In the year 2024, Mediwound distributed 0 USD as dividends.

In which currency does Mediwound pay out the dividend?

The dividends of Mediwound are distributed in USD.

Andere Kennzahlen von Mediwound

Our stock analysis for Mediwound Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Mediwound Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.